Objectives for Lane Benes:

1. Understand the prevalence of abnormal genes of lipoprotein metabolism.

2. Understand what types of genetic testing can be offered in the management of dyslipidemia and CVD.

3. Understand how genetic testing can alter patient management.



Objectives for Paul Larsen:


1. Understand indications for Impella.

2. Discuss future directions for usage.

Session date: 
06/07/2019 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Lane Benes, MD & Paul Larsen, MD